BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong W. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 [PMID: 33969059 DOI: 10.12998/wjcc.v9.i12.2763]
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2763.htm
Number Citing Articles
1
T. E. Kugler, I. S. Malovichko, V. B. Gnilitskaya, A. L. Khristulenko, N. F. Yarovaya. Proton Pump Inhibitors in the COVID-19 PandemicThe Russian Archives of Internal Medicine 2022; 12(4): 245 doi: 10.20514/2226-6704-2022-12-4-245-253
2
Verena Schöning, Felix Hammann. Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 PatientsPharmaceutics 2022; 14(9): 1828 doi: 10.3390/pharmaceutics14091828
3
M.A. Shokri, T. Moghadam Fard, T. Ramim, A. Hejrati, L. Hejrati, M. Mokhtare. What is the role of proton pump inhibitors consumption on the clinical presentation and severity of COVID-19 infection?Annales Pharmaceutiques Françaises 2022;  doi: 10.1016/j.pharma.2022.08.013
4
Hong-Bae Kim, Jung-Ha Kim, Bethany J. Wolf. Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2022; 78(3): 383 doi: 10.1007/s00228-021-03255-1